BRIEF published on 07/07/2026 at 15:00, 20 days 10 hours ago Piramal Pharma Reports FY2026 Achievements in Annual Report Innovation Sustainability Revenue Annual Report Global Growth
BRIEF published on 07/07/2026 at 15:00, 20 days 10 hours ago Piramal Pharma présente ses réalisations pour l'exercice 2026 dans son rapport annuel Innovation Durabilité Rapport Annuel Croissance Mondiale Revenu
PRESS RELEASE published on 07/07/2026 at 14:55, 20 days 10 hours ago Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones Piramal Pharma Limited's FY2026 Annual Report highlights global growth, innovation, and sustainability achievements. Revenue from operations and business insights included Sustainability Annual Report Global Growth Piramal Pharma Limited FY2026
BRIEF published on 04/28/2026 at 22:00, 2 months 29 days ago Piramal Pharma Limited Reports FY26 Financial Results Strategic Investment Revenue Decline Segment Growth Piramal Pharma Limited Financial Results 2026
BRIEF published on 04/28/2026 at 22:00, 2 months 29 days ago Piramal Pharma Limited publie ses résultats financiers pour l'exercice 2026 Investissement Stratégique Baisse Des Revenus Croissance Du Segment Piramal Pharma Limited Résultats Financiers 2026
PRESS RELEASE published on 04/28/2026 at 21:55, 2 months 29 days ago Piramal Pharma Limited Announces Results for Q4 and Full-year FY26 Piramal Pharma Limited announces Q4 and full-year FY26 results, highlighting growth in revenue, EBITDA margin, and key business developments amidst external disruptions. Read more here Financial Report Q4 Results Business Highlights FY26 Piramal Pharma Limited
BRIEF published on 01/29/2026 at 06:55, 5 months 29 days ago Piramal Pharma Reports Decline in Revenue and Profit for Q3 and 9M FY26 EBITDA Margin Revenue Decline Facility Expansion Biopharma Funding Kenalog Acquisition
BRIEF published on 01/29/2026 at 06:55, 5 months 29 days ago Piramal Pharma annonce une baisse de son chiffre d'affaires et de ses bénéfices pour le troisième trimestre et les neuf premiers mois de l'exercice 2026. Marge D'EBITDA Baisse Des Revenus Financement Biopharmaceutique Acquisition De Kenalog Extension Des Installations
PRESS RELEASE published on 01/29/2026 at 06:50, 5 months 29 days ago Piramal Pharma Limited Announces Results for Q3 and 9M FY26 Piramal Pharma Limited reports Q3 & 9M FY26 results with revenue impact, EBITDA efforts, and future growth prospects. Key highlights and financial performance discussed EBITDA Financial Performance Q3 Results Growth Prospects Piramal Pharma Limited
BRIEF published on 01/09/2026 at 22:00, 6 months 18 days ago Piramal Pharma Scores Higher on 2025 S&P Global Sustainability Assessment Pharmaceutical Industry Sustainability ESG Performance S&P Global CSA Piramal Pharma
Published on 07/27/2026 at 14:00, 11 hours 17 minutes ago Silver Storm Announces First Concentrate Shipment from La Parrilla
Published on 07/27/2026 at 13:30, 11 hours 47 minutes ago International Battery Metals Announces CEO Transition
Published on 07/27/2026 at 13:30, 11 hours 47 minutes ago Strategic Metals Options Yukon Copper-Gold Projects to GGL Resources Corp.
Published on 07/27/2026 at 13:30, 11 hours 47 minutes ago Nextech3D.ai Provides Update on Acquisition of Remaining ARway Shares; Closing Expected in October 2026
Published on 07/27/2026 at 13:30, 11 hours 47 minutes ago Reeflex Announces Updated Investor Presentation and Upcoming Investor Conference Participation
Published on 07/27/2026 at 23:05, 2 hours 12 minutes ago Quantinuum to Report Second Quarter Financial Results on August 11, 2026
Published on 07/27/2026 at 22:45, 2 hours 32 minutes ago EQS-Adhoc: Hypoport SE: Gross profit growth and significant increase in EBIT in H1/26
Published on 07/27/2026 at 21:15, 4 hours 2 minutes ago Xryma Plc announces the upcoming launch of XrymaCoin (XREUR), the regulated euro stablecoin designed to work like money
Published on 07/27/2026 at 20:50, 4 hours 27 minutes ago Pentixapharm Completes Capital Increase – New Shares Placed in Full
Published on 07/27/2026 at 20:40, 4 hours 37 minutes ago EQS-Adhoc: Pentixapharm Holding AG completes rights offering and private placement with significant oversubscription generating gross proceeds of approx. EUR 20.4 Million already today
Published on 07/27/2026 at 18:00, 7 hours 17 minutes ago Saint-Gobain accélère en Asie avec deux acquisitions ciblées
Published on 07/27/2026 at 18:00, 7 hours 17 minutes ago Saint-Gobain accelerates in Asia with two targeted acquisitions
Published on 07/27/2026 at 17:45, 7 hours 32 minutes ago Déclaration hebdomadaire de rachat d'actions
